Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol, including during the public health emergency (COVID-19) Guidance for industry United States. Department of Health and Human Services United States. Food and Drug Administration 2-Propanol Drug Compounding Ethanol Methanol COVID-19 The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from emerging infectious diseases, such as the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support continuity and response efforts to this pandemic. This guidance is intended to alert pharmaceutical manufacturers and pharmacists in Statelicensed pharmacies or Federal facilities who engage in drug compounding to the potential public health hazard of alcohol (ethyl alcohol or ethanol) or isopropyl alcohol contaminated with or substituted with methanol. FDA is aware of reports of fatal methanol poisoning of consumers who ingested alcohol-based hand sanitizers that were manufactured with methanol or methanol-contaminated ethanol. FDA has also received numerous reports of dermal toxicity associated with such products. [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021 United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Veterinary Medicine (U.S.), issuing body. Technical Report Text 1 online resource (1 PDF file (10 pages)). nlm:nlmuid-9918250311506676-pdf 9918250311506676 http://resource.nlm.nih.gov/9918250311506676 English United States The National Library of Medicine believes this item to be in the public domain. https://creativecommons.org/publicdomain/mark/1.0